Ascent-backed Naari to acquire drug applications portfolio to boost US biz

By Bruhadeeswaran R

  • 08 Jun 2020
Premium
Credit: Pixabay

Ascent Capital-backed Naari Pharma Pvt. Ltd is set to acquire a portfolio of abbreviated new drug applications (ANDAs) from a...

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Become a Premium member
Already a member? Click here to log in.